Standout Papers

FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors 2019 2026 2021 2023 752
  1. FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors (2019)
    Leigh Marcus, Steven J. Lemery et al. Clinical Cancer Research
  2. FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors (2021)
    Leigh Marcus, Lola A. Fashoyin‐Aje et al. Clinical Cancer Research

Immediate Impact

2 by Nobel laureates 3 from Science/Nature 60 standout
Sub-graph 1 of 22

Citing Papers

Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy
2024 Standout
Regulatory mechanisms of PD-1/PD-L1 in cancers
2024 Standout

Works of Leigh Marcus being referenced

FDA Approval Summary: Pembrolizumab for the First-line Treatment of Patients with MSI-H/dMMR Advanced Unresectable or Metastatic Colorectal Carcinoma
2021
FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors
2019 Standout

Author Peers

Author Last Decade Papers Cites
Leigh Marcus 1020 340 464 426 16 1.5k
S Hellman 796 356 403 437 23 1.9k
Felix Chu 625 248 524 235 19 1.6k
Gwen Mazoujian 685 586 269 544 31 2.0k
Priyanka Shivdasani 642 252 647 344 11 1.3k
Irina Linkov 593 250 345 271 26 1.4k
Frauke Bentzien 657 278 510 296 12 2.0k
J Richard 1174 152 470 282 38 2.0k
Andy Sherrod 775 279 516 109 39 1.5k
Remedios Penetrante 587 322 492 393 35 1.5k
Kevin Norwood 1232 348 479 227 37 1.7k

All Works

Loading papers...

Rankless by CCL
2026